Image via Inc42 (India)
Immuneel Therapeutics: Product Launch
Immuneel commercialised Qartemi (CAR-T therapy for Non-Hodgkin Lymphoma) in late 2024 and has treated 100+ patients. Now focusing on expanding to leukemia treatment and advancing solid tumor programs.
Source: Inc42 (India)
The leadership read
Requires Commercial/Sales leadership for Qartemi rollout, Medical Affairs executives, Patient Access/Reimbursement specialists, Clinical Trial Management leads for leukemia and solid tumor programs, and Market Access executives for new indications.
Market context: the MitchelLake Talent Market Index reads 108.5 — Hot (+10.8 vs prior month); Asia signal share is easing (-2.1pts).
MitchelLake in this thematic
Case study
Executive Search Fintech CPO
Spenmo
Our work · 2019
Chief Technology Officer (CTO)
SEEK Limited
Asia · Technology/Employment Services · technology transformation · regional integration
Our work · 2019
Director Product Engineering
SEEK Limited
Asia · Technology · digital-transformation · cross-border